Emergent BioSolutions Inc at Bank of America Healthcare Conference Transcript
(technical difficulty) Bob Burrows, Vice President of Investor Relations; and Rich Lindahl, our Chief Financial Officer.
For those of you that don't know, Emergent BioSolutions is a kind of a global biopharmaceutical company that is specialized in kind of public health threats and combating public health threats. And with that, I'll go ahead and turn over to Rich, I don't know if you want to do an introduction or just kind of an overview and maybe talk about some of the recent events, and then we get into more of the dialogue here.
Sure. So thank you very much for having us. I appreciate it. Yes, as Larry said, we're a company that focuses on providing solutions to public health reps, whether they be kind of naturally, accidentally or deliberately occurring.
To that end, we have a suite of products and services, which we'll talk about in more detail as we go through the conversation centered around vaccines, therapeutics and drug-device
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
